#compounding-pharmacies

[ follow ]
#weight-loss-drugs

Drugmaker shut down after black schmutz found in injectable weight-loss drug

FDA warns about safety issues with compounded weight-loss drugs as pharmaceutical companies fight against them amid legal battles and differing interests.

The Future of Ozempic Is Coming Into Focus

The rising popularity of Ozempic alternatives continues despite expected supply increases due to significant pricing differences.

Thinking of buying Wegovy online. Here's what to know about compounding pharmacies

Compounded weight-loss drugs can offer a more affordable option compared to brand-name medications like Wegovy, potentially benefiting those struggling with insurance coverage and high costs.

Drugmaker shut down after black schmutz found in injectable weight-loss drug

FDA warns about safety issues with compounded weight-loss drugs as pharmaceutical companies fight against them amid legal battles and differing interests.

The Future of Ozempic Is Coming Into Focus

The rising popularity of Ozempic alternatives continues despite expected supply increases due to significant pricing differences.

Thinking of buying Wegovy online. Here's what to know about compounding pharmacies

Compounded weight-loss drugs can offer a more affordable option compared to brand-name medications like Wegovy, potentially benefiting those struggling with insurance coverage and high costs.
moreweight-loss-drugs
#tirzepatide

The Crackdown on Compounded GLP-1 Meds Has Begun

Eli Lilly is intensifying legal actions against compounded GLP-1 medications amid ongoing product shortages.

Drug makers can't make knockoff weight-loss drugs anymore-and they're mad

Compounding pharmacies are suing the FDA to continue producing tirzepatide imitations despite the drug's supply improving.
The FDA announced that the tirzepatide shortage has been resolved, impacting compounding pharmacies' operations.

Mounjaro and Zepbound Are No Longer in Shortage, F.D.A. Says

The FDA has resolved the tirzepatide shortage, improving access to brand-name drugs but disrupting the compounded medication market.

The Crackdown on Compounded GLP-1 Meds Has Begun

Eli Lilly is intensifying legal actions against compounded GLP-1 medications amid ongoing product shortages.

Drug makers can't make knockoff weight-loss drugs anymore-and they're mad

Compounding pharmacies are suing the FDA to continue producing tirzepatide imitations despite the drug's supply improving.
The FDA announced that the tirzepatide shortage has been resolved, impacting compounding pharmacies' operations.

Mounjaro and Zepbound Are No Longer in Shortage, F.D.A. Says

The FDA has resolved the tirzepatide shortage, improving access to brand-name drugs but disrupting the compounded medication market.
moretirzepatide

People are overdosing on off-brand weight-loss drugs, FDA warns

The FDA has approved injectable versions of semaglutide for weight-loss and diabetes, cautioning against dangerous imitations due to pricing and supply issues.
[ Load more ]